Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Antibodies to Human Herpesviruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.

Blomberg J, Rizwan M, Böhlin-Wiener A, Elfaitouri A, Julin P, Zachrisson O, Rosén A, Gottfries CG.

Front Immunol. 2019 Aug 14;10:1946. doi: 10.3389/fimmu.2019.01946. eCollection 2019.

2.

A randomised controlled trial of the monoaminergic stabiliser (-)-OSU6162 in treatment of myalgic encephalomyelitis/chronic fatigue syndrome.

Nilsson MKL, Zachrisson O, Gottfries CG, Matousek M, Peilot B, Forsmark S, Schuit RC, Carlsson ML, Kloberg A, Carlsson A.

Acta Neuropsychiatr. 2018 Jun;30(3):148-157. doi: 10.1017/neu.2017.35. Epub 2017 Dec 7.

PMID:
29212562
3.

Response to vitamin B12 and folic acid in myalgic encephalomyelitis and fibromyalgia.

Regland B, Forsmark S, Halaouate L, Matousek M, Peilot B, Zachrisson O, Gottfries CG.

PLoS One. 2015 Apr 22;10(4):e0124648. doi: 10.1371/journal.pone.0124648. eCollection 2015.

4.

Safety and tolerability of intracerebroventricular PDGF-BB in Parkinson's disease patients.

Paul G, Zachrisson O, Varrone A, Almqvist P, Jerling M, Lind G, Rehncrona S, Linderoth B, Bjartmarz H, Shafer LL, Coffey R, Svensson M, Mercer KJ, Forsberg A, Halldin C, Svenningsson P, Widner H, Frisén J, Pålhagen S, Haegerstrand A.

J Clin Invest. 2015 Mar 2;125(3):1339-46. doi: 10.1172/JCI79635. Epub 2015 Feb 17.

5.

Epitopes of microbial and human heat shock protein 60 and their recognition in myalgic encephalomyelitis.

Elfaitouri A, Herrmann B, Bölin-Wiener A, Wang Y, Gottfries CG, Zachrisson O, Pipkorn R, Rönnblom L, Blomberg J.

PLoS One. 2013 Nov 28;8(11):e81155. doi: 10.1371/journal.pone.0081155. eCollection 2013.

6.

No evidence for xenotropic murine leukemia-related virus infection in Sweden using internally controlled multiepitope suspension array serology.

Blomberg J, Blomberg F, Sjösten A, Sheikholvaezin A, Bölin-Wiener A, Elfaitouri A, Hessel S, Gottfries CG, Zachrisson O, Ohrmalm C, Jobs M, Pipkorn R.

Clin Vaccine Immunol. 2012 Sep;19(9):1399-410. doi: 10.1128/CVI.00391-12. Epub 2012 Jul 11.

7.

Murine gammaretrovirus group G3 was not found in Swedish patients with myalgic encephalomyelitis/chronic fatigue syndrome and fibromyalgia.

Elfaitouri A, Shao X, Mattsson Ulfstedt J, Muradrasoli S, Bölin Wiener A, Golbob S, Ohrmalm C, Matousek M, Zachrisson O, Gottfries CG, Blomberg J.

PLoS One. 2011;6(10):e24602. doi: 10.1371/journal.pone.0024602. Epub 2011 Oct 12.

8.

Toxicokinetics of mercury after long-term repeated exposure to thimerosal-containing vaccine.

Barregard L, Rekić D, Horvat M, Elmberg L, Lundh T, Zachrisson O.

Toxicol Sci. 2011 Apr;120(2):499-506. doi: 10.1093/toxsci/kfr009. Epub 2011 Jan 20.

PMID:
21252391
9.

Restorative effects of platelet derived growth factor-BB in rodent models of Parkinson's disease.

Zachrisson O, Zhao M, Andersson A, Dannaeus K, Häggblad J, Isacson R, Nielsen E, Patrone C, Rönnholm H, Wikstrom L, Delfani K, McCormack AL, Palmer T, Di Monte DA, Hill MP, Janson Lang AM, Haegerstrand A.

J Parkinsons Dis. 2011;1(1):49-63. doi: 10.3233/JPD-2011-0003.

PMID:
23939256
10.

The glucagon-like peptide 1 receptor agonist exendin-4 improves reference memory performance and decreases immobility in the forced swim test.

Isacson R, Nielsen E, Dannaeus K, Bertilsson G, Patrone C, Zachrisson O, Wikström L.

Eur J Pharmacol. 2011 Jan 10;650(1):249-55. doi: 10.1016/j.ejphar.2010.10.008. Epub 2010 Oct 14.

PMID:
20951130
11.

A European multicenter randomized double-blind placebo-controlled monotherapy clinical trial of milnacipran in treatment of fibromyalgia.

Branco JC, Zachrisson O, Perrot S, Mainguy Y; Multinational Coordinator Study Group.

J Rheumatol. 2010 Apr;37(4):851-9. doi: 10.3899/jrheum.090884. Epub 2010 Feb 15.

PMID:
20156949
12.

[Immunologic disturbances can explain chronic fatigue syndrome. Biological findings point towards somatogenesis].

Gottfries CG, Matousek M, Zachrisson O.

Lakartidningen. 2009 Sep 2-8;106(36):2209-10, 2212-5. Review. Swedish. No abstract available.

PMID:
19817178
13.

Association of MAOA gene functional promoter polymorphism with CSF dopamine turnover and atypical depression.

Aklillu E, Karlsson S, Zachrisson OO, Ozdemir V, Agren H.

Pharmacogenet Genomics. 2009 Apr;19(4):267-75. doi: 10.1097/FPC.0b013e328328d4d3.

PMID:
19214141
14.

PACAP38 increases vesicular monoamine transporter 2 (VMAT2) expression and attenuates methamphetamine toxicity.

Guillot TS, Richardson JR, Wang MZ, Li YJ, Taylor TN, Ciliax BJ, Zachrisson O, Mercer A, Miller GW.

Neuropeptides. 2008 Aug;42(4):423-34. doi: 10.1016/j.npep.2008.04.003. Epub 2008 Jun 3.

15.

Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinson's disease.

Bertilsson G, Patrone C, Zachrisson O, Andersson A, Dannaeus K, Heidrich J, Kortesmaa J, Mercer A, Nielsen E, Rönnholm H, Wikström L.

J Neurosci Res. 2008 Feb 1;86(2):326-38.

PMID:
17803225
16.

Overlapping regional distribution of CCK and TPPII mRNAs in Cynomolgus monkey brain and correlated levels in human cerebral cortex (BA 10).

Radu D, Tomkinson B, Zachrisson O, Weber G, de Belleroche J, Hirsch S, Lindefors N.

Brain Res. 2006 Aug 9;1104(1):175-82. Epub 2006 Jul 5.

PMID:
16822484
17.
18.

HPA axis activation determined by the CRH challenge test in patients with few versus multiple episodes of treatment-refractory depression.

Ehnvall A, Sjögren M, Zachrisson OC, Agren H.

Eur Arch Psychiatry Clin Neurosci. 2004 Dec;254(6):349-55. Epub 2004 Nov 12.

PMID:
15538608
19.

Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement.

Trysberg E, Blennow K, Zachrisson O, Tarkowski A.

Arthritis Res Ther. 2004;6(6):R551-6. Epub 2004 Sep 23.

20.

Functional bradykinin B1 receptors are expressed in nociceptive neurones and are upregulated by the neurotrophin GDNF.

Vellani V, Zachrisson O, McNaughton PA.

J Physiol. 2004 Oct 15;560(Pt 2):391-401. Epub 2004 Aug 19.

21.

PACAP promotes neural stem cell proliferation in adult mouse brain.

Mercer A, Rönnholm H, Holmberg J, Lundh H, Heidrich J, Zachrisson O, Ossoinak A, Frisén J, Patrone C.

J Neurosci Res. 2004 Apr 15;76(2):205-15.

PMID:
15048918
22.

Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism.

Heilig M, Zachrisson O, Thorsell A, Ehnvall A, Mottagui-Tabar S, Sjögren M, Asberg M, Ekman R, Wahlestedt C, Agren H.

J Psychiatr Res. 2004 Mar-Apr;38(2):113-21.

PMID:
14757324
23.

Immune modulation with a staphylococcal preparation in fibromyalgia/chronic fatigue syndrome: relation between antibody levels and clinical improvement.

Zachrisson O, Colque-Navarro P, Gottfries CG, Regland B, Möllby R.

Eur J Clin Microbiol Infect Dis. 2004 Feb;23(2):98-105. Epub 2004 Jan 20.

PMID:
14735403
24.

[Sick listing--"disaster" or incompetence in statistics and diagnostics?].

Gottfries CG, Regland B, Zachrisson O, Wålinder J.

Lakartidningen. 2003 May 22;100(21):1912-4. Swedish. No abstract available.

PMID:
12815878
25.

Subnormal alpha-2-adrenoceptor-mediated sedation during 6 months of sobriety in male type 1 alcohol-dependent subjects.

Berggren U, Berglund K, Eriksson M, Fahlke C, Zachrisson O, Balldin J.

Alcohol Alcohol. 2003 Jul-Aug;38(4):321-6.

PMID:
12814898
26.
27.

Treatment with staphylococcus toxoid in fibromyalgia/chronic fatigue syndrome--a randomised controlled trial.

Zachrisson O, Regland B, Jahreskog M, Jonsson M, Kron M, Gottfries CG.

Eur J Pain. 2002;6(6):455-66.

PMID:
12413434
28.

A rating scale for fibromyalgia and chronic fatigue syndrome (the FibroFatigue scale).

Zachrisson O, Regland B, Jahreskog M, Kron M, Gottfries CG.

J Psychosom Res. 2002 Jun;52(6):501-9.

PMID:
12069875
29.

Upregulation of bradykinin B2 receptor expression by neurotrophic factors and nerve injury in mouse sensory neurons.

Lee YJ, Zachrisson O, Tonge DA, McNaughton PA.

Mol Cell Neurosci. 2002 Feb;19(2):186-200.

PMID:
11860272
30.

Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values.

Sjögren M, Vanderstichele H, Agren H, Zachrisson O, Edsbagge M, Wikkelsø C, Skoog I, Wallin A, Wahlund LO, Marcusson J, Nägga K, Andreasen N, Davidsson P, Vanmechelen E, Blennow K.

Clin Chem. 2001 Oct;47(10):1776-81.

31.

No evident neuronal damage after electroconvulsive therapy.

Zachrisson OC, Balldin J, Ekman R, Naesh O, Rosengren L, Agren H, Blennow K.

Psychiatry Res. 2000 Oct 30;96(2):157-65.

PMID:
11063788
32.

Effects of antipsychotic drugs on cholecystokinin and preprotachykinin (substance P) mRNA expression in the rat hippocampal formation.

Zachrisson O, Nomikos GG, Marcus MM, Svensson TH, Lindefors N.

Eur Neuropsychopharmacol. 2000 Sep;10(5):355-63.

PMID:
10974607
33.

Subsensitive alpha-2-adrenoceptor function in male alcohol-dependent individuals during 6 months of abstinence.

Berggren U, Fahlke C, Norrby A, Zachrisson O, Balldin J.

Drug Alcohol Depend. 2000 Jan 1;57(3):255-60.

PMID:
10661676
34.

Cholecystokinin CCK(B) receptor mRNA isoforms: expression in schizophrenic brains.

Zachrisson O, de Belleroche J, Wendt KR, Hirsch S, Lindefors N.

Neuroreport. 1999 Nov 8;10(16):3265-8.

PMID:
10599831
35.

[Executive functions and serotonin activity in patients with depression. A connection mirrors the influence of serotonin on prefrontal cortex].

Degl'Innocenti A, Agren H, Sjögren M, Zachrisson O, Bäckman L.

Lakartidningen. 1999 Nov 10;96(45):4918-9. Review. Swedish. No abstract available.

PMID:
10596531
36.

The influence of prolactin response to d-fenfluramine on executive functioning in major depression.

Degl'Innocenti A, Agren H, Zachrisson O, Bäckman L.

Biol Psychiatry. 1999 Aug 15;46(4):512-7.

PMID:
10459401
37.

A tachykinin NK1 receptor antagonist, CP-122,721-1, attenuates kainic acid-induced seizure activity.

Zachrisson O, Lindefors N, Brené S.

Brain Res Mol Brain Res. 1998 Oct 1;60(2):291-5.

PMID:
9757066
38.

GABA release and GAD67 mRNA expression in rat hippocampus following entorhinal cortex activation.

Falkenberg T, Lindefors N, O'Connor WT, Zachrisson O, Camilli F, Ungerstedt U.

Brain Res Mol Brain Res. 1997 Sep;48(2):413-6.

PMID:
9332739
39.
40.
41.

Effects of chronic lithium and electroconvulsive stimuli on cholecystokinin mRNA expression in the rat brain.

Zachrisson O, Mathé AA, Lindefors N.

Brain Res Mol Brain Res. 1996 Dec 31;43(1-2):347-50.

PMID:
9037553
42.

[Cholecystokinin receptors. A target for tomorrow's psychopharmaceuticals?].

Zachrisson O, Lindefors N.

Lakartidningen. 1996 Mar 27;93(13):1225-7. Review. Swedish.

PMID:
8656838
43.

Neuronal coexistence of trkB and glutamic acid decarboxylase67 mRNAs in rat hippocampus.

Zachrisson O, Falkenberg T, Lindefors N.

Brain Res Mol Brain Res. 1996 Feb;36(1):169-73.

PMID:
9011754
44.

Region-specific effects of chronic lithium administration on neuropeptide Y and somatostatin mRNA expression in the rat brain.

Zachrisson O, Mathé AA, Stenfors C, Lindefors N.

Neurosci Lett. 1995 Jul 14;194(1-2):89-92.

PMID:
7478221
45.

Limbic effects of repeated electroconvulsive stimulation on neuropeptide Y and somatostatin mRNA expression in the rat brain.

Zachrisson O, Mathé AA, Stenfors C, Lindefors N.

Brain Res Mol Brain Res. 1995 Jul;31(1-2):71-85.

PMID:
7476035
46.

Differential expression of mRNAs for neurotrophins and their receptors after axotomy of the sciatic nerve.

Funakoshi H, Frisén J, Barbany G, Timmusk T, Zachrisson O, Verge VM, Persson H.

J Cell Biol. 1993 Oct;123(2):455-65.

Supplemental Content

Loading ...
Support Center